James Revkin, MD, is a cardiologist specializing in preventive cardiology. He serves as an attending physician at Mass General Brigham. His clinical focus includes cardiovascular risk prevention, vascular imaging to inform care, and cardiometabolic health. His research centers on cardiovascular outcomes and clinical trial design, vascular imaging biomarkers, and the development of cardiometabolic therapeutics. He brings a broad perspective spanning academic medicine and industry to advance innovation in heart health. A former Executive Director in Cardiovascular and Metabolic Diseases Clinical Development at Pfizer, he has been recognized with multiple awards at Massachusetts General Hospital. Dr. Revkin earned his medical degree from Brown University, completed his residency at Columbia-Presbyterian Medical Center, and pursued a fellowship in cardiovascular medicine at Yale University.
Attending Physician
Medical School
1977 – 1981
Residency
1981 – 1984
Fellowship
1984 – 1987